Why pediatric practices now face two 2026 vaccine schedules

In January 2026, HHS narrowed the federal childhood immunization schedule to 11 universally recommended vaccine-preventable diseases, moving RSV, hepatitis A, hepatitis B, rotavirus, influenza and meningococcal ACWY onto a risk-based or shared-clinical-decision tier (Georgetown University Center for Children and Families). Three weeks later the American Academy of Pediatrics published a competing 2026 schedule that keeps all 18 as routine and says it no longer partners with the CDC on one shared document (National Medical Association). For a practice tracking who fell behind and when to remind them, “on schedule” stopped having a single answer.

That split did not appear overnight. HHS Secretary Robert F. Kennedy Jr. had already dismissed all 17 sitting members of the Advisory Committee on Immunization Practices in June 2025 and repopulated it with a different panel; the CDC had separately dropped its COVID-19 recommendation for healthy children the month before that (Drug Topics). By the time the January memo landed, the document most pediatric practices had followed largely unchanged for two decades was already contested — the new count of 11 is the outcome of a year of that fight, not a routine annual update.

The federal cut is real, but even the “before” number is disputed

How many diseases the federal schedule covered before the cut depends on who did the counting. AJMC reported the reduction as a move from 17 diseases to 11 (AJMC). Coverage of the same decision memo compiled by Georgetown’s Center for Children and Families put the starting point at 18 (Georgetown University CCF). Neither figure is obviously wrong — a “disease count” moves depending on whether a combination shot like DTaP or MMR gets split into its components, and neither outlet spells out its own method. What both accounts agree on is the destination and the process: the change was communicated through a CDC-director-signed memo and press coverage rather than a public ACIP meeting, and a former CDC vaccine policy lead, Demetre Daskalakis, called it a “stealth” announcement that skipped “scientific process and a review of the data.” A disputed starting count is itself evidence of how fast and how opaque this particular change moved.

Your practice now answers to two “official” schedules

Historically, the AAP simply endorsed whatever ACIP and the CDC published, so a practice’s clinical guidance and its coverage guidance pointed at the same document. That link broke in January. The AAP’s 2026 policy statement keeps all 18 diseases as routine, including every one the federal schedule reclassified, and its Wisconsin chapter notes the organization “no longer” partners with the CDC to produce a single shared schedule because the federal changes “depart from longstanding medical evidence” (Wisconsin AAP). The National Medical Association then endorsed the AAP version outright, with President Roger A. Mitchell Jr. calling it “thoroughly researched and rooted in science” and describing the CDC’s changes as having “created unnecessary and harmful confusion about routine childhood vaccinations” (National Medical Association). The AAP’s own Andrew Racine, quoted by The Hill, put the practice-level stakes in similar terms: the CDC’s decision “will sow further chaos and confusion and erode confidence in immunizations” if practices and families don’t have one clear line to follow (The Hill). HHS, meanwhile, has said federal insurance programs will keep covering every vaccine previously recommended “without cost-sharing,” whatever tier it now sits in — an assurance about reimbursement, not about which body’s clinical guidance a practice should be handing to parents.

Catch-up cohorts need a per-vaccine flag, not one yes-or-no

Before this year, a practice’s catch-up logic could lean on a single reference: the CDC’s own catch-up table, which sets the acceptable interval for a child who missed a dose. That table still exists, but it now sits under a schedule that made roughly a third of its rows optional rather than routine. A child missing a rotavirus or hepatitis B dose is simultaneously “behind” under the AAP’s list and merely a conversation to have under the federal one — and a single “caught up / not caught up” flag on a chart can no longer tell a front-desk team which of those is true for that family. The practical fix is to re-tag catch-up status per vaccine rather than per child, and to record which schedule justified each recommendation, since Georgetown’s analysis also flags that Vaccines for Children program compliance is unresolved for the newly reclassified vaccines — the federal change was never run through the formal ACIP process that normally updates VFC eligibility (Georgetown University CCF). A practice that keeps telling a family a vaccine is “fully covered” without checking that against its state’s current VFC and Medicaid position is the one that absorbs the denied claim, or passes it on to the family that trusted the reminder.

The process skip matters as much as the disease count

Georgetown’s Center for Children and Families notes that the January 5 schedule was framed as an expedited alignment with “peer, developed countries,” and that a subsequent STAT News analysis of vaccine recommendations across 38 countries found the revised U.S. schedule made the country an outlier comparable only to Denmark (Georgetown University CCF). The scientific evidence behind the previously universal vaccines, Georgetown stresses, had not changed — the change was a priority shift among political leaders, communicated through news coverage, an HHS press release and a CDC-director-signed memo rather than a public ACIP vote published in MMWR.

That process skip has a direct billing and stocking consequence. The Vaccines for Children statute ties the covered list to what ACIP establishes and revises; because this schedule was not established through that path, Georgetown flags unresolved questions about whether “without cost-sharing” assurances for previously recommended vaccines will hold over time. Separately, CMS announced on December 30, 2025 that it was removing childhood immunization status (CIS-CH) and immunizations for adolescents (IMA-CH) from mandatory Medicaid and CHIP quality reporting — measures that still tracked hepatitis B, hepatitis A, rotavirus, influenza, meningococcal, Tdap and HPV among other doses (Georgetown University CCF). When the federal schedule drops vaccines from universal status and the quality measures that tracked them leave the mandatory set, a practice that still follows the AAP schedule is flying without the external scorecard it used to share with payers.

Stocking risk follows the same logic. Georgetown notes that after earlier COVID recommendation changes for children, many providers stopped stocking pediatric COVID vaccines because of regulatory confusion and financial risk for privately insured children. The same dynamic can hit any dose that moves from “routine for all” to shared decision-making if manufacturers anticipate lower demand or if private plans treat the new tier as optional in practice even when federal programs still list coverage.

Reminder cadence and consent copy need to change with it

A reminder that says “the CDC recommends this vaccine” used to be safe shorthand because it matched whatever the provider was about to say in the exam room. That’s no longer guaranteed. A family that gets a federal-schedule reminder for a now-shared-decision vaccine, then hears their own provider recommend it anyway, will reasonably wonder which system is out of date — and that gap is exactly the “confusion” both the AAP and the National Medical Association are warning about in public. The safer rewrite attributes the recommendation to the practice and the child’s own provider rather than to a single outside body, and it splits cadence by tier: a due-date nudge fits a routine dose, while a shared-decision vaccine calls for a prompt to schedule a conversation, not a default appointment. None of that changes what TCPA and HIPAA already require of the reminder itself — a text or autodialed call still needs the parent’s consent to be contacted that way, and a voicemail or SMS should still carry the minimum needed to get the family in the door rather than naming a specific vaccine and its newly contested status. Confused reminder copy is also a no-show risk on its own: a parent who isn’t sure whether a visit is required or optional is a parent who reschedules, and a payer that isn’t sure which schedule justifies a claim is a payer that delays it.

What your practice can do

• Pick one internal clinical standard, in writing. Whichever schedule your practice’s providers actually follow, document it so front-desk staff, nurses and providers give families the same answer instead of citing whichever authority is top of mind that day.
• Re-tag catch-up status per vaccine, not per child. A single “behind schedule” flag no longer maps to one standard; a family can be current on some vaccines and behind on others depending on which schedule is doing the counting.
• Confirm VFC and Medicaid position before promising coverage. With formal ACIP action unresolved for several reclassified vaccines, verify your state’s current stance before telling a family a dose is fully covered.
• Rewrite reminder scripts to cite the practice, not one outside authority. Attribute the recommendation to the child’s own provider, and separate due-date nudges for routine doses from conversation prompts for shared-decision vaccines.
• Keep TCPA and HIPAA discipline as the message changes. Consent requirements for automated calls and texts, and minimum-necessary rules for what a voicemail or SMS discloses, apply regardless of which schedule triggered the reminder.
• Decide stocking and ordering against your written clinical standard, not against last year’s standing order. A dose that is still routine under the AAP schedule but shared-decision under the federal one needs an explicit inventory and coverage check before the next well-child wave.

Operational checklist for the dual-schedule quarter

1. Document which schedule your providers follow; circulate it to front desk and nursing in one page.
2. Retag open catch-up charts per vaccine with the justifying schedule.
3. Verify VFC / Medicaid / Marketplace coverage for each reclassified antigen before the next reminder batch.
4. Rewrite reminder templates to cite the practice and the child’s provider; split routine due-date nudges from shared-decision conversation prompts.
5. Audit one week of denied or delayed claims tied to the reclassified vaccines and feed the results back into coverage language.

Practices working out how to keep catch-up tracking and reminder cadence coherent through this kind of regulatory split are dealing with the same operational question behind how Arbol supports practices in the United States.